November 29th, 202311/29/2023Takeda’s ADZYNMA (ADAMTS13, recombinant-krhn) Now Available for the Prophylactic and On-Demand Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP) in the U.S. GO TO THE US NEWSROOM>